Intended for healthcare professionals

Latest dermatology news

 

Key milestone for Biofrontera’s phase 3 skin cancer trial

Approximately 3.6 million cases of basal cell carcinoma are diagnosed in the US every year

27 Feb 2025

FDA gives Alys Pharmaceuticals IND clearance for alopecia areata trial

Approximately 700,000 people in the US currently have some form of alopecia areata

20 Feb 2025

UCB’s Bimzelx shows sustained disease control in hidradenitis suppurativa

The inflammatory skin disease affects about 1% of the population in most studied countries

13 Feb 2025

LEO and DEBRA Research announce rare skin disorder collaboration

The partners will aim to accelerate the development of treatments for epidermolysis bullosa

06 Feb 2025

Gilead and LEO announce $1.7bn inflammation deal

LEO will hold exclusive global rights to STAT6 topical formulations in dermatology

30 Jan 2025

Regeneron’s Libtayo shows promise in phase 3 high-risk skin cancer trial

Cutaneous squamous cell carcinoma affects approximately 1.8 million people in the US every year

23 Jan 2025

Bristol Myers Squibb shares promising phase 3 results for Sotyktu in psoriatic arthritis

More than eight million people in the US are living with psoriasis, and up to 30% will develop psoriatic arthritis

16 Jan 2025

FDA grants approval to Organon’s Vtama cream in atopic dermatitis

The inflammatory skin disease affects up to 10% of adults and 20% of children globally

09 Jan 2025

EMA committee recommends Galderma’s nemolizumab for prurigo nodularis and atopic dermatitis

The European Commission will now consider the recommendations as it makes its decision on the drug

02 Jan 2025

LEO Pharma receives MHRA approval for Anzupgo cream in chronic hand eczema

Approximately 70% of patients with severe cases of the condition have reported problems performing everyday activities

19 Dec 2024
12345678910...